Hospital diabetes management (Update 2026)
Abstract
This position statement presents the recommendations of the Austrian Diabetes Association for the management of patients with diabetes during inpatient stay and in the perioperative setting. These recommendations are based on current evidence with respect to glucose targets, insulin therapy and treatment with oral/injectable antihyperglycemic agents during hospitalization and in perioperative setting. Additionally, it discusses special situations such as intravenous insulin therapy, concomitant therapy with glucocorticoids and use of diabetes technology during hospitalization and the perioperative setting.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.